Ajinomoto Cambrooke sponsors documentary premiere
FEBRUARY 27, 2021 – Ajinomoto Cambrooke, Inc. sponsored the premiere of the award-winning documentary, “So What Can You Eat?”, on February 27, 2021.
Ajinomoto Cambrooke, Inc. hosted online seminar for our distribution partner in China and local PKU patients
JANUARY 8, 2021 Ajinomoto Cambrooke, Inc. hosted an online seminar, on December 19, 2020, for our distribution partner in China, as well as for local PKU patients. The focus was to provide the benefits of Glycomacropeptide (GMP) and our products made from it. Since the acquisition by Ajinomoto, Cambrooke has been exploring an opportunity…
Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs
Press Release: Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs. read more
New clues to healthy bones for those with PKU
New evidence – Glytactin supports bone health. read article Download clinical study
Cambrooke Therapeutics announces Tylactin™ COMPLETE Bars for the dietary management of Tyrosinemia (TYR).
AYER, Mass–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ COMPLETE Bars, a nutritionally complete medical food, available in a convenient portable format, for the dietary management of Tyrosinemia (TYR). Tylactin with GMP is made from a natural whole protein derived from…
INTRODUCING KETOVIE CAFÉ KWIK MIX 4.5:1
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, launches the long awaited baking mix, KetoVie Café Kwik Mix 4.5:1, to its popular line of a ketogenic foods. KetoVie Café Kwik Mix 4.5:1 is easy to use and has the versatility to make a…
INTRODUCING TYLACTIN RESTORE POWDER FOR TYROSINEMIA (TYR)
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ RESTORE Powder, a medical food hydration beverage, available in convenient portable single-serve stick-packs for the dietary management of Tyrosinemia (TYR). Tylactin with GMP is made from a natural whole protein derived…
INTRODUCING GLYTACTIN™ BUILD WITH THE PH BALANCE OF WATER
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of Glytactin BUILD, a unique medical food formula for the dietary management of Phenylketonuria (PKU). This latest addition to the glytactin family of PKU products was designed to enhance availability of the specialized…
Press Release: Cambrooke announces the new and improved Glytactin™ Complete Bar
AYER, Mass.–(BUSINESS WIRE)–Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, is pleased to announce a new and improved Glytactin Complete Bar, a Medical Food for the dietary management of Phenylketonuria (PKU). The new and improved Glytactin Complete Bar contains glytactin with glycomacropeptide (GMP) with all the…